These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14565991)

  • 21. Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats.
    Fu M; Xu S; Zhang J; Pang Y; Liu N; Su J; Tang C
    Heart Vessels; 1999; 14(6):283-8. PubMed ID: 10901483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture.
    Norris CM; Blalock EM; Chen KC; Porter NM; Landfield PW
    Neuroscience; 2002; 110(2):213-25. PubMed ID: 11958864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy.
    Koulmann N; Novel-Chaté V; Peinnequin A; Chapot R; Serrurier B; Simler N; Richard H; Ventura-Clapier R; Bigard X
    Am J Respir Crit Care Med; 2006 Sep; 174(6):699-705. PubMed ID: 16799071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.
    Gao H; Wang F; Wang W; Makarewich CA; Zhang H; Kubo H; Berretta RM; Barr LA; Molkentin JD; Houser SR
    J Mol Cell Cardiol; 2012 Nov; 53(5):657-67. PubMed ID: 22921230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides.
    Ronkainen JJ; Vuolteenaho O; Tavi P
    Endocrinology; 2007 Jun; 148(6):2815-20. PubMed ID: 17332063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway.
    Yatani A; Honda R; Tymitz KM; Lalli MJ; Molkentin JD
    J Mol Cell Cardiol; 2001 Feb; 33(2):249-59. PubMed ID: 11162130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
    Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional coupling of calcineurin and protein kinase A in mouse ventricular myocytes.
    Santana LF; Chase EG; Votaw VS; Nelson MT; Greven R
    J Physiol; 2002 Oct; 544(Pt 1):57-69. PubMed ID: 12356880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signalling mechanisms and the role of calcineurin in erythropoiesis.
    Magócsi M; Apáti A; Gáti R; Kolonics A
    Immunol Lett; 1999 May; 68(1):187-95. PubMed ID: 10397175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor.
    Yu H; Bot I; Sliedregt K; Xu X; Bot M; van Heiningen SH; van der Marel GA; Bennett MR; Overkleeft H; van Berkel TJ; Biessen EA
    Circ Res; 2012 Jan; 110(2):200-10. PubMed ID: 22116820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling.
    Mandal CC; Das F; Ganapathy S; Harris SE; Choudhury GG; Ghosh-Choudhury N
    J Biol Chem; 2016 Jan; 291(3):1148-61. PubMed ID: 26472929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene.
    Xia Y; McMillin JB; Lewis A; Moore M; Zhu WG; Williams RS; Kellems RE
    J Biol Chem; 2000 Jan; 275(3):1855-63. PubMed ID: 10636885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy.
    Zhu W; Zou Y; Shiojima I; Kudoh S; Aikawa R; Hayashi D; Mizukami M; Toko H; Shibasaki F; Yazaki Y; Nagai R; Komuro I
    J Biol Chem; 2000 May; 275(20):15239-45. PubMed ID: 10809760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation and rate limiting mechanisms of Ca2+ ATPase (SERCA2) expression in cardiac myocytes.
    Prasad AM; Inesi G
    Mol Cell Biochem; 2012 Feb; 361(1-2):85-96. PubMed ID: 21964539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurally-mediated increase in calcineurin activity regulates cardiac contractile function in absence of hypertrophy.
    Li J; Yatani A; Kim SJ; Takagi G; Irie K; Zhang Q; Karoor V; Hong C; Yang G; Sadoshima J; Depre C; Vatner DE; West MJ; Vatner SF
    Cardiovasc Res; 2003 Sep; 59(3):649-57. PubMed ID: 14499866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FHL2 binds calcineurin and represses pathological cardiac growth.
    Hojayev B; Rothermel BA; Gillette TG; Hill JA
    Mol Cell Biol; 2012 Oct; 32(19):4025-34. PubMed ID: 22851699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.